Literature DB >> 21965156

Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant.

Zhong-Wen Wu1, Hai-Feng Lu, Jianping Wu, Jian Zuo, Ping Chen, Ji-Fang Sheng, Shu-Sen Zheng, Lan-Juan Li.   

Abstract

This study aims to provide an overview of the diversity of intestinal Lactobacillus among Chinese patients with hepatitis B virus (HBV)-related decompensated cirrhosis and who received liver transplant for hepatitis B cirrhosis. Fecal samples were collected from 38 healthy volunteers, 61 patients with HBV-related decompensated cirrhosis (group LC) and 74 patients who had liver transplant for hepatitis B cirrhosis (group LT). Quantitative polymerase chain reaction technology with species-specific primers was applied to investigate lactobacilli 16S rDNA in crude DNA, extracted from fecal samples. Software package Statistical Package for the Social Sciences and Palaeontological Statistics for Windows was used to analyze the data. Lactobacilli population of the two patient groups was different from the healthy control subjects, principal differences being marked decrease in the population of Lactobacillus rhamnosus (p < 0.001 for both patient groups) and reduction in the frequency of Lactobacillus fermentus (p < 0.001 for group LC and p < 0.01 for group LT). Our findings on the frequency of lactobacilli population suggested decreased diversity in groups LC and LT (compared with the healthy controls (p < 0.001 and p < 0.01, respectively)). Patients tended to have less complex fecal lactobacilli composition than the healthy controls, especially in the group LC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965156     DOI: 10.1007/s00248-011-9945-1

Source DB:  PubMed          Journal:  Microb Ecol        ISSN: 0095-3628            Impact factor:   4.552


  46 in total

Review 1.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

2.  Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.

Authors:  Sabine Bartosch; Emma J Woodmansey; Jacqueline C M Paterson; Marion E T McMurdo; George T Macfarlane
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

3.  A novel species-specific PCR assay for identifying Lactobacillus fermentum.

Authors:  E M Dickson; M P Riggio; L Macpherson
Journal:  J Med Microbiol       Date:  2005-03       Impact factor: 2.472

4.  Rapid species identification within two groups of closely related lactobacilli using PCR primers that target the 16S/23S rRNA spacer region.

Authors:  F Berthier; S D Ehrlich
Journal:  FEMS Microbiol Lett       Date:  1998-04-01       Impact factor: 2.742

5.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

6.  Intestinal gram-negative bacterial overgrowth in vivo augments the in vitro response of Kupffer cells to endotoxin.

Authors:  T R Billiar; M A Maddaus; M A West; R D Curran; C A Wells; R L Simmons
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

7.  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Reinhold A Schiller; Jan M Langrehr; Sven Jonas; Stig Bengmark; Peter Neuhaus
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

8.  Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure.

Authors:  Lan-Juan Li; Zhong-Wen Wu; Dang-Sheng Xiao; Ji-Fang Sheng
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

9.  Deconjugation of bile acids by lactobacilli in the mouse small bowel.

Authors:  G W Tannock; A Tangerman; A Van Schaik; M A McConnell
Journal:  Appl Environ Microbiol       Date:  1994-09       Impact factor: 4.792

Review 10.  [Bacterial infections in liver cirrhosis].

Authors:  Mária Papp; Anikó Farkas; Miklós Udvardy; István Tornai
Journal:  Orv Hetil       Date:  2007-03-04       Impact factor: 0.540

View more
  21 in total

Review 1.  Interactions between the intestinal microbiome and liver diseases.

Authors:  Bernd Schnabl; David A Brenner
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

Review 2.  Gut microbial balance and liver transplantation: alteration, management, and prediction.

Authors:  Xinyao Tian; Zhe Yang; Fangzhou Luo; Shusen Zheng
Journal:  Front Med       Date:  2017-12-12       Impact factor: 4.592

3.  Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.

Authors:  Peng Chen; Manolito Torralba; Justin Tan; Mallory Embree; Karsten Zengler; Peter Stärkel; Jan-Peter van Pijkeren; Jessica DePew; Rohit Loomba; Samuel B Ho; Jasmohan S Bajaj; Ece A Mutlu; Ali Keshavarzian; Hidekazu Tsukamoto; Karen E Nelson; Derrick E Fouts; Bernd Schnabl
Journal:  Gastroenterology       Date:  2014-09-16       Impact factor: 22.682

4.  Starring role of toll-like receptor-4 activation in the gut-liver axis.

Authors:  Simone Carotti; Michele Pier Luca Guarino; Umberto Vespasiani-Gentilucci; Sergio Morini
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 5.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

Review 6.  The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.

Authors:  Niels van Best; Peter L Jansen; Sander S Rensen
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

Review 7.  Gut microbiota and allogeneic transplantation.

Authors:  Weilin Wang; Shaoyan Xu; Zhigang Ren; Jianwen Jiang; Shusen Zheng
Journal:  J Transl Med       Date:  2015-08-23       Impact factor: 5.531

8.  The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.

Authors:  Phillipp Hartmann; Wei-Chung Chen; Bernd Schnabl
Journal:  Front Physiol       Date:  2012-10-11       Impact factor: 4.566

Review 9.  Gut Microbiota and Host Reaction in Liver Diseases.

Authors:  Hiroshi Fukui
Journal:  Microorganisms       Date:  2015-10-28

10.  Correlation between cortisol levels and concurrent infection for hepatitis B cirrhosis patients and countermeasure analysis.

Authors:  Jian Zhang; Junwei Ma; Hongxin Wang; Junhong Li
Journal:  Exp Ther Med       Date:  2018-01-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.